Johnson & Johnson was ordered Thursday by a Dallas jury to pay $247 million to half a dozen patients who claimed the company hid defects in its Pinnacle artificial hips, its third big-dollar loss over the products.
Impressive pharma pipeline has JNJ in a position of recognizing significant future top line growth. Based on a DCF, DDM, and comps model, JNJ is certainly not on the clearance rack, but has an enticing valuation for the benefits you get from the stock.
(Reuters) - A California jury on Thursday ruled in favor of Johnson & Johnson in a lawsuit by a woman who said she developed the cancer mesothelioma after being exposed to asbestos in the company's talc-based products including J&J's Baby Powder.
PORTAGE, MI - Pfizer Inc. is looking to fill 200 new skilled trades, engineering and manufacturing jobs. The jobs are related to work that is ongoing at its mammoth pharmaceutical manufacturing plant at 7000 Portage Road, as well as the expansion it ...
SAN FRANCISCO, Nov. 13, 2017 /PRNewswire/ -- Johnson & Johnson Innovation LLC, in collaboration with Johnson & Johnson Consumer Inc., today announced the launch of the Digital Beauty QuickFire Challenge.
The new program is called the Digital Beauty QuickFire Challenge, and will encourage startup companies to compete in the creation novel and forward-thinking products for consumers that promote both skincare and beauty.